Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2014-05-06 Director's Dealing
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Director's Dealing 2014
Director's Dealing Classification · 99% confidence The document is very short (226 characters) and is written in Danish. It explicitly states that Novozymes is making public transactions according to Section 28a of the Securities Trading Act, referencing ISIN DK0060336014 and Novozymes B shares (NZYM B). It concludes by stating, 'Læs hele meddelelsen i pdf format' (Read the entire announcement in pdf format). This structure—a brief notification pointing to a full PDF—strongly suggests this is an announcement about a filing rather than the filing itself. Since the content relates to transactions by insiders or related parties (implied by the reference to the Securities Trading Act and specific share codes), the most fitting category is Director's Dealing (DIRS). However, given the 'MENU VS MEAL' rule, and the fact that it's a brief announcement pointing to a full document, it could also be a general Regulatory Filing (RNS). Director's Dealing (DIRS) is more specific to the content (transactions under the Securities Trading Act). I will classify it as DIRS, as the content is clearly about insider transactions, even if announced briefly.
2014-05-06 Danish
Director's Dealing 2014
Director's Dealing Classification · 100% confidence The document text is extremely short (232 characters) and explicitly states that transactions are being reported 'in accordance with Section 28a of the Danish Securities Trading Act' concerning Novozymes B shares. Crucially, it directs the reader to 'Read the full announcement in PDF format.' This structure—a brief notification pointing to a full document—fits the definition of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since the content relates to specific transactions (though not explicitly director dealings, it's a regulatory disclosure), and it's a short announcement pointing elsewhere, RPA is the most appropriate classification based on the 'MENU VS MEAL' rule, as it is announcing the publication of the detailed filing. If the content were detailed insider trading reports, DIRS would apply, but here it's a regulatory notice of a transaction report.
2014-05-06 English
Transaction in Own Shares 2014
Transaction in Own Shares Classification · 100% confidence The document text is very short (263 characters) and describes a specific transaction: Novozymes buying back shares (2,073,972 shares for 502.8 million DKK) under a previously announced share repurchase program. The final sentence, 'Læs hele meddelelsen i pdf format' (Read the full announcement in pdf format), strongly suggests this is a brief announcement about a transaction rather than the full regulatory filing detailing the transaction. The description matches 'Transaction in Own Shares' (POS), which covers share repurchases. Since it is a brief announcement referencing a full document, it could potentially be RPA, but the content is highly specific to share transactions, making POS the most accurate primary classification.
2014-05-02 Danish
Transaction in Own Shares 2014
Transaction in Own Shares Classification · 100% confidence The document text explicitly states that Novozymes has purchased an accumulated number of shares under a 'stock buyback program'. This action directly relates to the company managing its own shares, which corresponds to the 'Transaction in Own Shares' definition. The document is very short (285 chars) and directs the user to read the full announcement in PDF format, suggesting it is an announcement of the transaction rather than the detailed regulatory filing itself. However, the core subject matter is the share repurchase, making 'POS' the most specific fit among the primary filing types. Since it is an announcement of the transaction, it could potentially be RPA/RNS, but POS is the most descriptive category for the *content* (share repurchase). Given the strong content match to 'Transaction in Own Shares', POS is selected.
2014-05-02 English
Transaction in Own Shares 2014
Transaction in Own Shares Classification · 99% confidence The document text is extremely short (230 characters) and explicitly states that transactions were reported 'In accordance with Section 28a of the Danish Securities Trading Act' concerning Novozymes B shares. It directs the reader to 'Read the full announcement in PDF format.' This structure—a brief notification pointing to a full document—strongly suggests this is an announcement about a filing rather than the filing itself. Since the content relates to transactions by insiders/related parties (implied by the context of securities trading act reporting on share transactions), the most specific category would be Director's Dealing (DIRS). However, given the very short length and the instruction to read the full announcement elsewhere, it fits the 'MENU VS MEAL' rule, suggesting a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since DIRS is a specific type of regulatory filing, and this is clearly about share transactions by insiders/related parties, DIRS is the most accurate content classification, even if it's an announcement wrapper. If DIRS were not available, RPA or RNS would be considered. Given the specific nature of the content (share transactions reporting), DIRS is the best fit.
2014-04-29 English
Regulatory Filings 2014
Regulatory Filings Classification · 99% confidence The document is very short (226 characters) and is written in Danish. It explicitly states that Novozymes is making public transactions according to Section 28a of the Securities Trading Act, referencing ISIN DK0060336014 and Novozymes B shares (NZYM B). It concludes by stating, 'Læs hele meddelelsen i pdf format' (Read the entire announcement in pdf format). This structure—a brief notification pointing to a full PDF—strongly suggests this is an announcement about a filing rather than the filing itself. Since the content relates to transactions by insiders or related parties (implied by the reference to the Securities Trading Act and specific share codes), the most fitting category is Director's Dealing (DIRS). However, given the 'MENU VS MEAL' rule, and the fact that it's a brief announcement pointing to a full document, it could also be a general Regulatory Filing (RNS). Director's Dealing (DIRS) is more specific to the content (transactions under the Securities Trading Act). I will classify it as DIRS, as the content is clearly about insider transactions, even if announced briefly.
2014-04-29 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.